Top Markets
Coin of the day
PacificHealth Laboratories, Inc. PacificHealth Laboratories, Inc.

PacificHealth Laboratories, Inc.

PHLI
Rang in Aktien #39559
PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing... PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing nutritional products designed to boost overall health and enhance athletic performance for consumers both within the United States and internationally. The company's offerings predominantly target key aspects of athletic performance, such as optimal sports performance, proper hydration, sustained energy (fueling), and efficient muscle recovery. PHLI's product line includes notable items like ENDUROX R4, a drink formulated for muscle recovery; ACCELERADE, a protein-powered sports beverage; energy gels such as ACCEL GEL and 2ND SURGE; the exercise supplement ENDUROX EXCEL; and Body Glove Surge. Additionally, they provide ACCELERADE HYDRO, a specific formulation for less intense workouts, which supports hydration, energy, and recovery before, during, and after physical activity. Reaching consumers through diverse distribution channels, PHLI's products are available in sports specialty and natural product retailers and chains, as well as directly through their official website. PacificHealth Laboratories, Inc. was founded in 1995 and is headquartered in Matawan, New Jersey.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2025-02-11
Marktkapitalisierung
$438.31K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel PacificHealth Laboratories, Inc. (PHLI)
Gewinn für PacificHealth Laboratories, Inc. (PHLI)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von PacificHealth Laboratories, Inc. betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von PacificHealth Laboratories, Inc. von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$20.38B -
US
$9.83B -
FR
$2.94B -
US
$1.55B -
IN
- -
DE